NCT06293261

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 5,047 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: —

Summary

This study is to confirm the long-term efficacy and safety of Rosuampin Tab. in patients with hypertension and hypercholesterolemia

Detailed description

All treatments, such as drug administration and clinical laboratory tests performed after Rosuampine administration, are performed according to the investigator's medical judgment, and information to be confirmed in this observational study is collected for up to 12 months.

Conditions

• Hypertension
• Hypercholesterolemia

Interventions

Type	Name	Description
DRUG	Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg	Experimental only, not included active and placebo comparator

Timeline

• Start date: 2020-06-27
• Primary completion: 2024-03-31
• Completion: 2024-03-31
• First posted: 2024-03-05
• Last updated: 2025-01-22

Locations

39 sites across 1 country: South Korea